Blow-Fill-Seal Technology Global Market Report 2024

The global blow-fill-seal technology market has grown rapidly in recent years. It will grow from $3.28 billion in 2023 to $3.64 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historic period can be attributed to several factors. Continuous improvement and standardization played a crucial role in enhancing the efficiency and reliability of blow-fill-seal (BFS) technology. The global market penetration of this technology expanded, driven by its versatile packaging design capabilities that cater to diverse product requirements. The reduced environmental impact associated with BFS technology, coupled with its scalability in production, contributed to its adoption and growth during the historic period.

The global blow-fill-seal technology market is expected to see rapid growth in the next few years. It will grow to $5.67 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The anticipated growth in the forecast period can be attributed to several factors. There is an expected expansion across various industries, driven by the increased demand for sterile packaging solutions. The focus on convenience and safety is likely to fuel the adoption of blow-fill-seal (BFS) technology, particularly with the rising preference for unit dose packaging. Additionally, the growing demand for personalized medicine is anticipated to contribute to the overall growth of BFS technology. Key trends in the forecast period include the diversification of BFS technology into various sectors, a notable shift towards unit dose packaging, integration with Industry 4.0 practices, and an increased focus on packaging biologics and vaccines.

The blow-fill-seal (BFS) technology market is poised for substantial growth, propelled by the expanding pharmaceutical industry. Renowned for its involvement in pharmaceutical research, development, and production, the industry benefits significantly from BFS technology. This technology is instrumental in packaging products, ensuring protection against physical damage, chemical contamination, and microbiological threats. Notably, the Indian pharmaceutical market, according to the Indian Economic Survey 2021, reached US$ 42 billion in 2021 and is projected to surge to US$ 65 billion by 2024, further expanding to a substantial US$ 120-130 billion by 2030. The accelerating pharmaceutical industry is thus a key driver fueling the growth of the blow-fill-seal technology market.

Anticipated growth in the blow-fill-seal technology market is closely linked to the rising demand in the personal care sector. Personal care products, integral to daily hygiene routines, witness increased efficiency and quality in manufacturing through blow-fill-seal technology. This technology offers personal care product manufacturers benefits such as enhanced stability, cost-effectiveness, and packaging design flexibility. Notably, the Bureau of Labor Statistics reported a 12.3% increase in average consumer expenditure on personal care products in 2022, reaching $866, up from $771 in 2021. This surge in personal care demand stands as a significant factor driving the growth of the blow-fill-seal technology market.

Key trends in the blow-fill-seal technology market are defined by technological innovations, particularly the advancement toward molding technology for lightweight product innovation. Major industry players, such as Berry Global Healthcare, are adopting advanced molding technology to create lightweight components, exemplified by the launch of Cyrano, a lightweight dual-port blow-fill-seal closure. This innovation not only ensures ease of use on the latest blow-fill-seal machines but also delivers superior performance, enhancing drug administration, improving patient safety, and protecting product integrity. Technological innovations continue to shape the blow-fill-seal technology market, driving advancements in product design and manufacturing.

Major companies operating in the blow-fill-seal technology market are directing their focus on innovative products, specifically ampoules, to drive market revenues. Ampoules, small sealed vials used to preserve samples, have become a popular product choice due to their impactful contributions to skincare routines. For instance, Reviderm AG, a Germany-based skincare and aesthetic products company, launched ampoules with highly effective ingredient blends. These ampoules, tailored to target specific skin issues, offer a powerful complement to skincare regimens, characterized by high concentrations of active substances and a commitment to optimal outcomes.

In April 2021, SK Capital Partners, a US-based private investment firm, executed the acquisition of Catalent Inc. for an undisclosed amount. This strategic move allowed Catalent to concentrate on its core business of developing biological, inhaled, and oral medications while expanding scientific capabilities into cutting-edge modalities like gene and cell therapies. The acquisition aimed to strengthen Catalent's position in the Contract Development and Manufacturing Organization (CDMO) industry, emphasizing operational excellence, customer satisfaction, innovation, and a partnership-driven strategy. Catalent Inc., a US-based company acquired by SK Capital Partners, plays a pivotal role in the pharmaceutical and biotechnology industries, notably in blow-fill-seal (BFS) technology.

Major companies operating in the blow-fill-seal technology market report are Amanta Healthcare Ltd., Unither Pharmaceuticals SAS, Curida AS, Unipharma LLC, Weiler Engineering Inc., GlaxoSmithKline PLC, Nephron Pharmaceuticals Corporation, Horizon Therapeutics PLC, Brevetti Angela SRL, Recipharm AB, Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH, Unicep Packaging LLC, Mahanagar Engineering Pvt. Ltd., Catalent Inc., The Ritedose Corporation, LyondellBasell Industries NV, Nupharma Group, Birgi Mefar Group, Takeda Pharmaceutical Company Limited, Pfizer Inc., Sanofi SA, Novartis International AG, Merck & Co. Inc., Johnson & Johnson Private Limited, Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, F Hoffmann-La Roche Ltd., Fresenius Kabi AG, B. Braun Melsungen AG, Sandoz International GmbH, Baxter International Inc., West Pharmaceutical Services Inc., and Gerresheimer AG

North America was the largest region in the blow-fill-seal technology market in 2023. The regions covered in the blow-fill-seal technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blow-fill-seal technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Blow-fill-seal technology is capable of producing various products, including bottles, ampoules, vials, prefilled syringes, and injectables. Bottles, in this context, refer to rigid or semi-rigid containers typically crafted from materials like glass or plastic, featuring a relatively narrow neck or mouth and often without a handle. These containers are manufactured using various materials such as polyethylene (PE), polypropylene (PP), and other materials like EVOH, accommodating both small and large volumes. The applications of blow-fill-seal technology span across pharmaceuticals, food and beverage, cosmetics, personal care, and other relevant industries.

This report provides blow-fill-seal technology market statistics, including blow-fill-seal technology industry global market size, regional shares, competitors with a blow-fill-seal technology market share, detailed blow-fill-seal technology market segments, market trends and opportunities, and any further data you may need to thrive in the blow-fill-seal technology industry. This blow-fill-seal technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blow-fill-seal (BFS) technology market consists of revenues earned by entities by providing services such as packaging, process control, and system automation. The market value includes the value of related goods sold by the service provider or included within the service offering. The blow-fill-seal technology market also includes sales of syringes and injectable products, ophthalmic and inhalation products, and other products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.